Variant report
Variant | esv1519674 |
---|---|
Chromosome Location | chr4:1048085-1048689 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:1048335..1050594-chr4:1053315..1054904,2 | K562 | blood: | |
2 | chr4:1042064..1045606-chr4:1047862..1051205,4 | K562 | blood: | |
3 | chr4:1046102..1048749-chr4:1049067..1050606,2 | MCF-7 | breast: | |
4 | chr4:978985..981201-chr4:1048637..1050224,2 | MCF-7 | breast: | |
5 | chr4:1045118..1048090-chr4:1052343..1053975,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000145214 | chromatin interactions |
ENSG00000127415 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112920560 | chr4:1048167-1048168 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200383974 | chr4:1048169-1048170 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112609004 | chr4:1048177-1048178 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373329644 | chr4:1048214-1048215 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376759572 | chr4:1048235-1048236 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs578257023 | chr4:1048253-1048254 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545554925 | chr4:1048257-1048258 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369235343 | chr4:1048296-1048297 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563739420 | chr4:1048300-1048301 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs62294694 | chr4:1048307-1048308 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | mRNA abundance |
11 | rs377415130 | chr4:1048345-1048346 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113555289 | chr4:1048347-1048348 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113344601 | chr4:1048397-1048398 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561088302 | chr4:1048398-1048399 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112955884 | chr4:1048405-1048406 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs55881376 | chr4:1048409-1048410 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199651266 | chr4:1048437-1048438 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374029096 | chr4:1048477-1048478 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374240253 | chr4:1048501-1048502 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201857504 | chr4:1048502-1048503 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375646601 | chr4:1048523-1048524 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370061968 | chr4:1048546-1048547 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373755512 | chr4:1048567-1048568 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528454377 | chr4:1048628-1048629 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367875163 | chr4:1048629-1048630 | Weak transcription Bivalent Enhancer Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374246867 | chr4:1048639-1048640 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs71604340 | chr4:1048646-1048647 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs368631240 | chr4:1048649-1048650 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs71640375 | chr4:1048652-1048653 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs71604341 | chr4:1048657-1048658 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs71640376 | chr4:1048668-1048669 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs372226662 | chr4:1048687-1048688 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs71604342 | chr4:1048689-1048690 | Weak transcription Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Wolf-Hirschhorn syndrome | 21549014 | CNVD |
Breast cancer | 21806811 | CNVD |
Wolf-Hirschhorn syndrome | 22283845 | CNVD |
Wolf-Hirschhorn syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Wolf-Hirschhorn syndrome | 22470819 | CNVD |
Wolf-Hirschhorn syndrome | 18541967 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17142309 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 22297974 | CNVD |
Breast cancer | 20932292 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:1040800-1048600 | Weak transcription | Right Atrium | heart |
2 | chr4:1041200-1049200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr4:1042200-1052200 | Weak transcription | Gastric | stomach |
4 | chr4:1046600-1049200 | Weak transcription | Lung | lung |
5 | chr4:1047000-1049200 | Active TSS | Right Ventricle | heart |
6 | chr4:1047200-1049200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr4:1047200-1049200 | Weak transcription | Spleen | Spleen |
8 | chr4:1047400-1049800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr4:1047600-1049400 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr4:1048000-1049200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr4:1048000-1049200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr4:1048400-1049200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
13 | chr4:1048600-1049200 | Active TSS | Left Ventricle | heart |
14 | chr4:1048600-1049400 | Active TSS | Brain Hippocampus Middle | brain |
15 | chr4:1048600-1049600 | Active TSS | Pancreas | Pancrea |
16 | chr4:1048600-1049800 | Active TSS | Right Atrium | heart |